Anebulo Pharmaceuticals, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
OTC.Pink
SCHEDULE 13D/A: Major Shareholder Anebulo Pharmaceuticals Increases Stake to 51.1% and Enters Key Governance Agreements
Anebulo Pharmaceuticals, Inc. announces that Aron R. English and affiliated entities now beneficially own 51.1% of its common stock, following a private placement and new lock-up and support agreements.